chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sensation of foreign body, Sepsis, Urinary tract infection, Urine analysis abnormal, Urine leukocyte esterase positive
Clinical narrative: COVID Vaccine Breakthrough CAse  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/8/21  12/8/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who presented to the ED today due to altered mental status. She lives at facility and was noted to be confused with some low blood pressures and was sent to the ED.   Upon exam patient notes she is currently better than she was.  She notes her only pain is just below the waist. Denies any chest pain or shortness of breath.  Feels things are stuck in her esophagus.  She has a very dry mouth.  She otherwise denies headaches, nausea, abdominal pain, diarrhea, or constipation.   In the ED she was initially afebrile with a blood pressure 141/117 but then decreased to 91/55.  She was saturating 96% on room air with pulse 97. Labs are notable for sodium 132, ALP 135, lactic acid 2.2, WBC 35.13.  Urine with large leukocyte esterase, loaded bacteria, no RBCs.  Although patient asymptomatic, she did test COVID positive.  She received ceftriaxone and 2.5 L of fluid in the ED.   Surgical history:  Ileostomy, chronic G-tube, chronic suprapubic catheter  Social history:  Lives at facility  FH: Noncontributory  12/11/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who had presented to the ER on 12/8/21 due to AMS and low BPs. Pt was found to have UTI with sepsis thought 2/2 indwelling suprapubic catheter. Urology was consulted and the catheter was changed out. Urine studies came back sensitive to ceftriaxone but resistant to Keflex. Given pt has allergies to Bactrim, pt will continue IM ceftriaxone 1gm for a total of 10 course given complicated UTI.  Oxybutynin was initiated by Urology which was continued on discharge.  Pt is doing well. No pain, no drainage around catheter site. Has been stable without fevers for the last few days. Will f/u with urology given renal stones in 2-3 weeks. F/U with PCP within 1-2 weeks after discharge. Holding Home Metoprolol on discharge with BP to be monitored outpatient and resumed if appropriate. Pt discharge back to facility in stable condition.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccine breakthrough infection, White blood cell count increased
Clinical narrative: COVID Vaccine Breakthrough CAse  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/8/21  12/8/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who presented to the ED today due to altered mental status. She lives at facility and was noted to be confused with some low blood pressures and was sent to the ED.   Upon exam patient notes she is currently better than she was.  She notes her only pain is just below the waist. Denies any chest pain or shortness of breath.  Feels things are stuck in her esophagus.  She has a very dry mouth.  She otherwise denies headaches, nausea, abdominal pain, diarrhea, or constipation.   In the ED she was initially afebrile with a blood pressure 141/117 but then decreased to 91/55.  She was saturating 96% on room air with pulse 97. Labs are notable for sodium 132, ALP 135, lactic acid 2.2, WBC 35.13.  Urine with large leukocyte esterase, loaded bacteria, no RBCs.  Although patient asymptomatic, she did test COVID positive.  She received ceftriaxone and 2.5 L of fluid in the ED.   Surgical history:  Ileostomy, chronic G-tube, chronic suprapubic catheter  Social history:  Lives at facility  FH: Noncontributory  12/11/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who had presented to the ER on 12/8/21 due to AMS and low BPs. Pt was found to have UTI with sepsis thought 2/2 indwelling suprapubic catheter. Urology was consulted and the catheter was changed out. Urine studies came back sensitive to ceftriaxone but resistant to Keflex. Given pt has allergies to Bactrim, pt will continue IM ceftriaxone 1gm for a total of 10 course given complicated UTI.  Oxybutynin was initiated by Urology which was continued on discharge.  Pt is doing well. No pain, no drainage around catheter site. Has been stable without fevers for the last few days. Will f/u with urology given renal stones in 2-3 weeks. F/U with PCP within 1-2 weeks after discharge. Holding Home Metoprolol on discharge with BP to be monitored outpatient and resumed if appropriate. Pt discharge back to facility in stable condition.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bacterial test positive, Bladder catheterisation, Blood alkaline phosphatase increased, Blood culture negative, Blood lactic acid normal
Clinical narrative: COVID Vaccine Breakthrough CAse  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/8/21  12/8/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who presented to the ED today due to altered mental status. She lives at facility and was noted to be confused with some low blood pressures and was sent to the ED.   Upon exam patient notes she is currently better than she was.  She notes her only pain is just below the waist. Denies any chest pain or shortness of breath.  Feels things are stuck in her esophagus.  She has a very dry mouth.  She otherwise denies headaches, nausea, abdominal pain, diarrhea, or constipation.   In the ED she was initially afebrile with a blood pressure 141/117 but then decreased to 91/55.  She was saturating 96% on room air with pulse 97. Labs are notable for sodium 132, ALP 135, lactic acid 2.2, WBC 35.13.  Urine with large leukocyte esterase, loaded bacteria, no RBCs.  Although patient asymptomatic, she did test COVID positive.  She received ceftriaxone and 2.5 L of fluid in the ED.   Surgical history:  Ileostomy, chronic G-tube, chronic suprapubic catheter  Social history:  Lives at facility  FH: Noncontributory  12/11/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who had presented to the ER on 12/8/21 due to AMS and low BPs. Pt was found to have UTI with sepsis thought 2/2 indwelling suprapubic catheter. Urology was consulted and the catheter was changed out. Urine studies came back sensitive to ceftriaxone but resistant to Keflex. Given pt has allergies to Bactrim, pt will continue IM ceftriaxone 1gm for a total of 10 course given complicated UTI.  Oxybutynin was initiated by Urology which was continued on discharge.  Pt is doing well. No pain, no drainage around catheter site. Has been stable without fevers for the last few days. Will f/u with urology given renal stones in 2-3 weeks. F/U with PCP within 1-2 weeks after discharge. Holding Home Metoprolol on discharge with BP to be monitored outpatient and resumed if appropriate. Pt discharge back to facility in stable condition.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood sodium decreased, Blood urine, COVID-19, Crystal urine present, Culture urine positive
Clinical narrative: COVID Vaccine Breakthrough CAse  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/8/21  12/8/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who presented to the ED today due to altered mental status. She lives at facility and was noted to be confused with some low blood pressures and was sent to the ED.   Upon exam patient notes she is currently better than she was.  She notes her only pain is just below the waist. Denies any chest pain or shortness of breath.  Feels things are stuck in her esophagus.  She has a very dry mouth.  She otherwise denies headaches, nausea, abdominal pain, diarrhea, or constipation.   In the ED she was initially afebrile with a blood pressure 141/117 but then decreased to 91/55.  She was saturating 96% on room air with pulse 97. Labs are notable for sodium 132, ALP 135, lactic acid 2.2, WBC 35.13.  Urine with large leukocyte esterase, loaded bacteria, no RBCs.  Although patient asymptomatic, she did test COVID positive.  She received ceftriaxone and 2.5 L of fluid in the ED.   Surgical history:  Ileostomy, chronic G-tube, chronic suprapubic catheter  Social history:  Lives at facility  FH: Noncontributory  12/11/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who had presented to the ER on 12/8/21 due to AMS and low BPs. Pt was found to have UTI with sepsis thought 2/2 indwelling suprapubic catheter. Urology was consulted and the catheter was changed out. Urine studies came back sensitive to ceftriaxone but resistant to Keflex. Given pt has allergies to Bactrim, pt will continue IM ceftriaxone 1gm for a total of 10 course given complicated UTI.  Oxybutynin was initiated by Urology which was continued on discharge.  Pt is doing well. No pain, no drainage around catheter site. Has been stable without fevers for the last few days. Will f/u with urology given renal stones in 2-3 weeks. F/U with PCP within 1-2 weeks after discharge. Holding Home Metoprolol on discharge with BP to be monitored outpatient and resumed if appropriate. Pt discharge back to facility in stable condition.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Enterococcus test positive, Imaging procedure abnormal, Inflammation, Leukocytosis, Lipase normal
Clinical narrative: COVID Vaccine Breakthrough CAse  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/8/21  12/8/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who presented to the ED today due to altered mental status. She lives at facility and was noted to be confused with some low blood pressures and was sent to the ED.   Upon exam patient notes she is currently better than she was.  She notes her only pain is just below the waist. Denies any chest pain or shortness of breath.  Feels things are stuck in her esophagus.  She has a very dry mouth.  She otherwise denies headaches, nausea, abdominal pain, diarrhea, or constipation.   In the ED she was initially afebrile with a blood pressure 141/117 but then decreased to 91/55.  She was saturating 96% on room air with pulse 97. Labs are notable for sodium 132, ALP 135, lactic acid 2.2, WBC 35.13.  Urine with large leukocyte esterase, loaded bacteria, no RBCs.  Although patient asymptomatic, she did test COVID positive.  She received ceftriaxone and 2.5 L of fluid in the ED.   Surgical history:  Ileostomy, chronic G-tube, chronic suprapubic catheter  Social history:  Lives at facility  FH: Noncontributory  12/11/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who had presented to the ER on 12/8/21 due to AMS and low BPs. Pt was found to have UTI with sepsis thought 2/2 indwelling suprapubic catheter. Urology was consulted and the catheter was changed out. Urine studies came back sensitive to ceftriaxone but resistant to Keflex. Given pt has allergies to Bactrim, pt will continue IM ceftriaxone 1gm for a total of 10 course given complicated UTI.  Oxybutynin was initiated by Urology which was continued on discharge.  Pt is doing well. No pain, no drainage around catheter site. Has been stable without fevers for the last few days. Will f/u with urology given renal stones in 2-3 weeks. F/U with PCP within 1-2 weeks after discharge. Holding Home Metoprolol on discharge with BP to be monitored outpatient and resumed if appropriate. Pt discharge back to facility in stable condition.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mental status changes, Nitrite urine present, Pain, Prohormone brain natriuretic peptide increased, Pyrexia
Clinical narrative: COVID Vaccine Breakthrough CAse  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/8/21  12/8/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who presented to the ED today due to altered mental status. She lives at facility and was noted to be confused with some low blood pressures and was sent to the ED.   Upon exam patient notes she is currently better than she was.  She notes her only pain is just below the waist. Denies any chest pain or shortness of breath.  Feels things are stuck in her esophagus.  She has a very dry mouth.  She otherwise denies headaches, nausea, abdominal pain, diarrhea, or constipation.   In the ED she was initially afebrile with a blood pressure 141/117 but then decreased to 91/55.  She was saturating 96% on room air with pulse 97. Labs are notable for sodium 132, ALP 135, lactic acid 2.2, WBC 35.13.  Urine with large leukocyte esterase, loaded bacteria, no RBCs.  Although patient asymptomatic, she did test COVID positive.  She received ceftriaxone and 2.5 L of fluid in the ED.   Surgical history:  Ileostomy, chronic G-tube, chronic suprapubic catheter  Social history:  Lives at facility  FH: Noncontributory  12/11/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who had presented to the ER on 12/8/21 due to AMS and low BPs. Pt was found to have UTI with sepsis thought 2/2 indwelling suprapubic catheter. Urology was consulted and the catheter was changed out. Urine studies came back sensitive to ceftriaxone but resistant to Keflex. Given pt has allergies to Bactrim, pt will continue IM ceftriaxone 1gm for a total of 10 course given complicated UTI.  Oxybutynin was initiated by Urology which was continued on discharge.  Pt is doing well. No pain, no drainage around catheter site. Has been stable without fevers for the last few days. Will f/u with urology given renal stones in 2-3 weeks. F/U with PCP within 1-2 weeks after discharge. Holding Home Metoprolol on discharge with BP to be monitored outpatient and resumed if appropriate. Pt discharge back to facility in stable condition.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Staphylococcus test positive, Tachycardia, Troponin, Urine abnormality
Clinical narrative: COVID Vaccine Breakthrough CAse  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/8/21  12/8/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who presented to the ED today due to altered mental status. She lives at facility and was noted to be confused with some low blood pressures and was sent to the ED.   Upon exam patient notes she is currently better than she was.  She notes her only pain is just below the waist. Denies any chest pain or shortness of breath.  Feels things are stuck in her esophagus.  She has a very dry mouth.  She otherwise denies headaches, nausea, abdominal pain, diarrhea, or constipation.   In the ED she was initially afebrile with a blood pressure 141/117 but then decreased to 91/55.  She was saturating 96% on room air with pulse 97. Labs are notable for sodium 132, ALP 135, lactic acid 2.2, WBC 35.13.  Urine with large leukocyte esterase, loaded bacteria, no RBCs.  Although patient asymptomatic, she did test COVID positive.  She received ceftriaxone and 2.5 L of fluid in the ED.   Surgical history:  Ileostomy, chronic G-tube, chronic suprapubic catheter  Social history:  Lives at facility  FH: Noncontributory  12/11/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who had presented to the ER on 12/8/21 due to AMS and low BPs. Pt was found to have UTI with sepsis thought 2/2 indwelling suprapubic catheter. Urology was consulted and the catheter was changed out. Urine studies came back sensitive to ceftriaxone but resistant to Keflex. Given pt has allergies to Bactrim, pt will continue IM ceftriaxone 1gm for a total of 10 course given complicated UTI.  Oxybutynin was initiated by Urology which was continued on discharge.  Pt is doing well. No pain, no drainage around catheter site. Has been stable without fevers for the last few days. Will f/u with urology given renal stones in 2-3 weeks. F/U with PCP within 1-2 weeks after discharge. Holding Home Metoprolol on discharge with BP to be monitored outpatient and resumed if appropriate. Pt discharge back to facility in stable condition.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine analysis abnormal, Urine leukocyte esterase positive, White blood cell count increased
Clinical narrative: COVID Vaccine Breakthrough CAse  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/8/21  12/8/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who presented to the ED today due to altered mental status. She lives at facility and was noted to be confused with some low blood pressures and was sent to the ED.   Upon exam patient notes she is currently better than she was.  She notes her only pain is just below the waist. Denies any chest pain or shortness of breath.  Feels things are stuck in her esophagus.  She has a very dry mouth.  She otherwise denies headaches, nausea, abdominal pain, diarrhea, or constipation.   In the ED she was initially afebrile with a blood pressure 141/117 but then decreased to 91/55.  She was saturating 96% on room air with pulse 97. Labs are notable for sodium 132, ALP 135, lactic acid 2.2, WBC 35.13.  Urine with large leukocyte esterase, loaded bacteria, no RBCs.  Although patient asymptomatic, she did test COVID positive.  She received ceftriaxone and 2.5 L of fluid in the ED.   Surgical history:  Ileostomy, chronic G-tube, chronic suprapubic catheter  Social history:  Lives at facility  FH: Noncontributory  12/11/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who had presented to the ER on 12/8/21 due to AMS and low BPs. Pt was found to have UTI with sepsis thought 2/2 indwelling suprapubic catheter. Urology was consulted and the catheter was changed out. Urine studies came back sensitive to ceftriaxone but resistant to Keflex. Given pt has allergies to Bactrim, pt will continue IM ceftriaxone 1gm for a total of 10 course given complicated UTI.  Oxybutynin was initiated by Urology which was continued on discharge.  Pt is doing well. No pain, no drainage around catheter site. Has been stable without fevers for the last few days. Will f/u with urology given renal stones in 2-3 weeks. F/U with PCP within 1-2 weeks after discharge. Holding Home Metoprolol on discharge with BP to be monitored outpatient and resumed if appropriate. Pt discharge back to facility in stable condition.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I received the vaccine on 5/12/2022 and on the 16th I tested positive for Covid. The next day I had symptoms of a cold mild congestion and runny nose.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Feeling hot, Headache, Joint range of motion decreased
Clinical narrative: chills,  nausea, "can't use my arm"- only lift "an inch", pain "feels like someone shot me" "on fire" unable to find thermometer, headache, no appetite
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain
Clinical narrative: chills,  nausea, "can't use my arm"- only lift "an inch", pain "feels like someone shot me" "on fire" unable to find thermometer, headache, no appetite
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Injection site pain, Injection site swelling, Malaise
Clinical narrative: On 4/28/22, pt., received her 2nd Moderna vaccination in her right deltoid around approx. 3:30pm via homebound visit. Pt. was originally scheduled to receive her vaccination on 4/22/22, but requested to reschedule because she ?was not feeling well? and had ?taken a sleeping pill?, so she would be unable to stay awake for visit. Pt.?s mother, also resided in the home and was present for vaccination. During screening, pt. reported having a chronic cough and sore throat and reported that she had tested negative for covid and had unremarkable findings upon examination by physician. Supervisors were consulted via phone prior to administering vaccination about still providing vaccination, and it was determined that pt. was able to still receive vaccination. Pt. requested she be given the vaccination still and did not wish to delay. Pt. denied any major incident after her previous Moderna vaccination, denied allergy to any ingredients in vaccine, denied previous hx of issue with vaccines. During visit, pt. reported prescription use of morphine, oxycodone, and Xanax. Pt. denied severe reactions to previous vaccinations, but reported ?I was supposed to die over 30 years ago? in regards to food allergies and swelling in her arm during childhood. Pt. requested vaccination be given in right arm due to left side weakness and nerve damage from previous surgery administered. Pt. was observed for over 30 minutes after administration without incident. During visit pt. was instructed to call 911 and seek emergency services if pt. had any serious complications after vaccination and to follow up with PCP.   On 5/18/22, Mom of pt, that pt, had pain and swelling at the injection site (RD) for just under a week after administration.  Mom stated after that about 7 to 10 days after the vaccine, the patient began experiencing ?finger cramping? bilaterally, as well as ?pain in her knees and all her joints?. Pt. denied having these symptoms after the first Moderna vaccine and reported only having soreness in her arm. Were alerted of this via email and informed to follow up with incident report, VAERS, and following up with pt. Pt. denied following up with PCP. Pt. reported her symptoms to her allergist and pain management doctor. Pt. reported prescription of Morphine and Oxycodone.  Upon phone screening by prior to home visit it was reported, pt. resides in hospital bed in the living room of her home. Pt. reported hx of Hip replacement, compression fractures in spine, nerve damage in left arm, and limited diet. Pt. reported she was allergic to eggs, ?most antibiotics?, and pork. Pt. received her 1st dose of Moderna on 12/3/2021 via a homebound visit with another agency, DeliveredRx (Moderna, lot: 058H21A). During home visit, pt. reported ability to ambulate to the bathroom.  Attempted to contact pt. on 5/20/22 at 10:54am, left VM for pt. to contact DOH back. Will continue to follow up with pt.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Oropharyngeal pain, SARS-CoV-2 test negative
Clinical narrative: On 4/28/22, pt., received her 2nd Moderna vaccination in her right deltoid around approx. 3:30pm via homebound visit. Pt. was originally scheduled to receive her vaccination on 4/22/22, but requested to reschedule because she ?was not feeling well? and had ?taken a sleeping pill?, so she would be unable to stay awake for visit. Pt.?s mother, also resided in the home and was present for vaccination. During screening, pt. reported having a chronic cough and sore throat and reported that she had tested negative for covid and had unremarkable findings upon examination by physician. Supervisors were consulted via phone prior to administering vaccination about still providing vaccination, and it was determined that pt. was able to still receive vaccination. Pt. requested she be given the vaccination still and did not wish to delay. Pt. denied any major incident after her previous Moderna vaccination, denied allergy to any ingredients in vaccine, denied previous hx of issue with vaccines. During visit, pt. reported prescription use of morphine, oxycodone, and Xanax. Pt. denied severe reactions to previous vaccinations, but reported ?I was supposed to die over 30 years ago? in regards to food allergies and swelling in her arm during childhood. Pt. requested vaccination be given in right arm due to left side weakness and nerve damage from previous surgery administered. Pt. was observed for over 30 minutes after administration without incident. During visit pt. was instructed to call 911 and seek emergency services if pt. had any serious complications after vaccination and to follow up with PCP.   On 5/18/22, Mom of pt, that pt, had pain and swelling at the injection site (RD) for just under a week after administration.  Mom stated after that about 7 to 10 days after the vaccine, the patient began experiencing ?finger cramping? bilaterally, as well as ?pain in her knees and all her joints?. Pt. denied having these symptoms after the first Moderna vaccine and reported only having soreness in her arm. Were alerted of this via email and informed to follow up with incident report, VAERS, and following up with pt. Pt. denied following up with PCP. Pt. reported her symptoms to her allergist and pain management doctor. Pt. reported prescription of Morphine and Oxycodone.  Upon phone screening by prior to home visit it was reported, pt. resides in hospital bed in the living room of her home. Pt. reported hx of Hip replacement, compression fractures in spine, nerve damage in left arm, and limited diet. Pt. reported she was allergic to eggs, ?most antibiotics?, and pork. Pt. received her 1st dose of Moderna on 12/3/2021 via a homebound visit with another agency, DeliveredRx (Moderna, lot: 058H21A). During home visit, pt. reported ability to ambulate to the bathroom.  Attempted to contact pt. on 5/20/22 at 10:54am, left VM for pt. to contact DOH back. Will continue to follow up with pt.
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 15.0
Sex: F
Vaccine: HEPA, HEPA
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Doctor ordered Hep B and patient was given Hep A
Age: 15.0
Sex: F
Vaccine: HEPA, HEPA
Symptoms: Wrong product administered
Clinical narrative: Doctor ordered Hep B and patient was given Hep A
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalization with covid; fully vaccinated
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Central nervous system lesion, Computerised tomogram abnormal, Diplopia, Headache, Laboratory test
Clinical narrative: In late March, started experiencing right side headache that persisted. After 2 weeks, experienced double vision that persisted for 2 days. I went to eye dr and was told I had sixth nerve palsy. Went to ER. No sign of stroke. Stayed in hospital for a few days and received one dose of anti-biotics.  I'm still experiencing double vision. Had another CT scan and spot was still there. Drs think it is a cranial lesion. I will be meeting w/ a Neuro-surgeon to get lesion removed.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, VIth nerve paralysis
Clinical narrative: In late March, started experiencing right side headache that persisted. After 2 weeks, experienced double vision that persisted for 2 days. I went to eye dr and was told I had sixth nerve palsy. Went to ER. No sign of stroke. Stayed in hospital for a few days and received one dose of anti-biotics.  I'm still experiencing double vision. Had another CT scan and spot was still there. Drs think it is a cranial lesion. I will be meeting w/ a Neuro-surgeon to get lesion removed.
Age: 74.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Biopsy bone normal, Brain natriuretic peptide increased, C-reactive protein increased, COVID-19, Condition aggravated
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 5/13/2022 Discharge Date: 5/19/2022  PRESENTING PROBLEM: Elevated C-reactive protein (CRP)  Elevated brain natriuretic peptide (BNP) level History of MRSA infection Other acute osteomyelitis of left foot (HCC)  Stage 3b chronic kidney disease (HCC)  COVID-19  Osteomyelitis (HCC)    HOSPITAL COURSE: 74-year-old with osteomyelitis of left 5th metatarsal head admitted for IV antibiotics and Podiatry consultation and resulting surgery.  Patient also with COVID.  Has remained on room air during his entire stay.   Patient with osteomyelitis on presentation.  Patient underwent  partial-amputation of left 5th ray on May 15th:.  Patient was maintained on IV vancomycin because of previous culture showing MRSA infection.  Repeat cultures did grow out Staph aureus.  Bone biopsies done during her surgery did not show any evidence osteomyelitis within the 5th metatarsal.     Infectious Disease was consulted they recommended using doxycycline for a total of 14 days of treatment.  Patient completed 4 days of treatment or hospitalization.  Patient will be discharged on 10 days of doxycycline.  Overall patient is doing well.  He received a dressing change this morning.  Patient will have home health care for further dressing changes per Podiatry recommendations.  Patient has been given a dose of doxycycline during hospitalization because of a previous questionable allergy to tetracycline.  If tolerates, will discharge home antibiotics as outlined above.
Age: 74.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Culture positive, Osteomyelitis, Staphylococcus test positive, Surgery, Toe amputation
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 5/13/2022 Discharge Date: 5/19/2022  PRESENTING PROBLEM: Elevated C-reactive protein (CRP)  Elevated brain natriuretic peptide (BNP) level History of MRSA infection Other acute osteomyelitis of left foot (HCC)  Stage 3b chronic kidney disease (HCC)  COVID-19  Osteomyelitis (HCC)    HOSPITAL COURSE: 74-year-old with osteomyelitis of left 5th metatarsal head admitted for IV antibiotics and Podiatry consultation and resulting surgery.  Patient also with COVID.  Has remained on room air during his entire stay.   Patient with osteomyelitis on presentation.  Patient underwent  partial-amputation of left 5th ray on May 15th:.  Patient was maintained on IV vancomycin because of previous culture showing MRSA infection.  Repeat cultures did grow out Staph aureus.  Bone biopsies done during her surgery did not show any evidence osteomyelitis within the 5th metatarsal.     Infectious Disease was consulted they recommended using doxycycline for a total of 14 days of treatment.  Patient completed 4 days of treatment or hospitalization.  Patient will be discharged on 10 days of doxycycline.  Overall patient is doing well.  He received a dressing change this morning.  Patient will have home health care for further dressing changes per Podiatry recommendations.  Patient has been given a dose of doxycycline during hospitalization because of a previous questionable allergy to tetracycline.  If tolerates, will discharge home antibiotics as outlined above.
Age: 74.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Wound treatment
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 5/13/2022 Discharge Date: 5/19/2022  PRESENTING PROBLEM: Elevated C-reactive protein (CRP)  Elevated brain natriuretic peptide (BNP) level History of MRSA infection Other acute osteomyelitis of left foot (HCC)  Stage 3b chronic kidney disease (HCC)  COVID-19  Osteomyelitis (HCC)    HOSPITAL COURSE: 74-year-old with osteomyelitis of left 5th metatarsal head admitted for IV antibiotics and Podiatry consultation and resulting surgery.  Patient also with COVID.  Has remained on room air during his entire stay.   Patient with osteomyelitis on presentation.  Patient underwent  partial-amputation of left 5th ray on May 15th:.  Patient was maintained on IV vancomycin because of previous culture showing MRSA infection.  Repeat cultures did grow out Staph aureus.  Bone biopsies done during her surgery did not show any evidence osteomyelitis within the 5th metatarsal.     Infectious Disease was consulted they recommended using doxycycline for a total of 14 days of treatment.  Patient completed 4 days of treatment or hospitalization.  Patient will be discharged on 10 days of doxycycline.  Overall patient is doing well.  He received a dressing change this morning.  Patient will have home health care for further dressing changes per Podiatry recommendations.  Patient has been given a dose of doxycycline during hospitalization because of a previous questionable allergy to tetracycline.  If tolerates, will discharge home antibiotics as outlined above.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Condition aggravated, Discomfort, Erythema, Inflammation
Clinical narrative: My psoriasis became inflamed and spread all over my body with the exception of my face. It was itchy and burning and very very red and scaly, and extremely uncomfortable. It was amplified and enhanced beyond normal. After each dose there was a slight outbreak of it but that normally comes from food, but this dose was so intense that I needed to seek medical help. The doctor is sending me to an oncologist. He gave me some creams that are definitely helping. It's clearing up now, but its not fully gone.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Psoriasis, Skin exfoliation
Clinical narrative: My psoriasis became inflamed and spread all over my body with the exception of my face. It was itchy and burning and very very red and scaly, and extremely uncomfortable. It was amplified and enhanced beyond normal. After each dose there was a slight outbreak of it but that normally comes from food, but this dose was so intense that I needed to seek medical help. The doctor is sending me to an oncologist. He gave me some creams that are definitely helping. It's clearing up now, but its not fully gone.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Decreased appetite, Fall, Mental status changes, Pollakiuria
Clinical narrative: ALTERED MENTAL STATUS, FALLS,  LOSS OF APPETITE
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: ALTERED MENTAL STATUS, FALLS,  LOSS OF APPETITE
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain, Alopecia, Blood test, Computerised tomogram
Clinical narrative: I had a lot of fatigue and numbness in the leg, I couldn't hardly walk, my nose and arms. I couldn't even sleep, from my neck into my back. I had a really bad headache. I have a lot of cramping in my gut. I felt swollen, bloating and I had Tinnitus in both ears along with dizziness. I had brain fog, high blood pressure an high heart rate for about 3 weeks. I had diarrhea, vomiting, I had double vision with the left eye and slow vision in both eyes. I had tingling all over my body, it not as worse now. My muscles is very loose. Even in my throat was hurting, my feet got swollen and turned blue. I even had a rash on my arms, chest and abdomen. I am still having these issue. I am even experiencing hair lost.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Cyanosis, Diabetes mellitus, Diarrhoea, Diplopia, Dizziness
Clinical narrative: I had a lot of fatigue and numbness in the leg, I couldn't hardly walk, my nose and arms. I couldn't even sleep, from my neck into my back. I had a really bad headache. I have a lot of cramping in my gut. I felt swollen, bloating and I had Tinnitus in both ears along with dizziness. I had brain fog, high blood pressure an high heart rate for about 3 weeks. I had diarrhea, vomiting, I had double vision with the left eye and slow vision in both eyes. I had tingling all over my body, it not as worse now. My muscles is very loose. Even in my throat was hurting, my feet got swollen and turned blue. I even had a rash on my arms, chest and abdomen. I am still having these issue. I am even experiencing hair lost.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Gait disturbance, Headache, Heart rate increased
Clinical narrative: I had a lot of fatigue and numbness in the leg, I couldn't hardly walk, my nose and arms. I couldn't even sleep, from my neck into my back. I had a really bad headache. I have a lot of cramping in my gut. I felt swollen, bloating and I had Tinnitus in both ears along with dizziness. I had brain fog, high blood pressure an high heart rate for about 3 weeks. I had diarrhea, vomiting, I had double vision with the left eye and slow vision in both eyes. I had tingling all over my body, it not as worse now. My muscles is very loose. Even in my throat was hurting, my feet got swollen and turned blue. I even had a rash on my arms, chest and abdomen. I am still having these issue. I am even experiencing hair lost.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Hypoaesthesia, Hypotonia, Magnetic resonance imaging, Ophthalmological examination
Clinical narrative: I had a lot of fatigue and numbness in the leg, I couldn't hardly walk, my nose and arms. I couldn't even sleep, from my neck into my back. I had a really bad headache. I have a lot of cramping in my gut. I felt swollen, bloating and I had Tinnitus in both ears along with dizziness. I had brain fog, high blood pressure an high heart rate for about 3 weeks. I had diarrhea, vomiting, I had double vision with the left eye and slow vision in both eyes. I had tingling all over my body, it not as worse now. My muscles is very loose. Even in my throat was hurting, my feet got swollen and turned blue. I even had a rash on my arms, chest and abdomen. I am still having these issue. I am even experiencing hair lost.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Paraesthesia, Peripheral swelling, Rash, Sleep disorder
Clinical narrative: I had a lot of fatigue and numbness in the leg, I couldn't hardly walk, my nose and arms. I couldn't even sleep, from my neck into my back. I had a really bad headache. I have a lot of cramping in my gut. I felt swollen, bloating and I had Tinnitus in both ears along with dizziness. I had brain fog, high blood pressure an high heart rate for about 3 weeks. I had diarrhea, vomiting, I had double vision with the left eye and slow vision in both eyes. I had tingling all over my body, it not as worse now. My muscles is very loose. Even in my throat was hurting, my feet got swollen and turned blue. I even had a rash on my arms, chest and abdomen. I am still having these issue. I am even experiencing hair lost.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Thyroid disorder, Tinnitus, Visual impairment, Vomiting
Clinical narrative: I had a lot of fatigue and numbness in the leg, I couldn't hardly walk, my nose and arms. I couldn't even sleep, from my neck into my back. I had a really bad headache. I have a lot of cramping in my gut. I felt swollen, bloating and I had Tinnitus in both ears along with dizziness. I had brain fog, high blood pressure an high heart rate for about 3 weeks. I had diarrhea, vomiting, I had double vision with the left eye and slow vision in both eyes. I had tingling all over my body, it not as worse now. My muscles is very loose. Even in my throat was hurting, my feet got swollen and turned blue. I even had a rash on my arms, chest and abdomen. I am still having these issue. I am even experiencing hair lost.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was Cardinal refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: PATIENT RECEIVED J&J DOSE AT 17 YO. J&J VACCINE IS APPROVED FOR AGES 18 YO AND UP.